9701/13381US=65 / Biol/Mol
Murthy A, Cruz-Munoz W, Khokha R. TIMPs: extracellular modifiers in cancer development. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 373-400. ISBN 978-0-387-69056-8.

TIMPS; MODIFICADORES EXTRACELULARES; DESENVOLVIMENTO DO CANCER; PROLIFERACAO CELULAR; APOPTOSE; ANGIOGENESE; CONTATO CELULAR; MOTILIDADE; MODELOS IN VIVO; BIOLOGIA DO CANCER

9702/13381US=65 / Biol/Mol
Mueller SC, Artym VV, Kelly T. Invadopodia: interface for invasion. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 403-31. ISBN 978-0-387-69056-8.

INVADOPODIA; COMPONENTES MOLECULARES; MEMBRANAS; ATIVIDADE PROTEOLITICA; ACTINA; CORTACTINA; NUCLEOS; PSEUDOPODIA; SALIENCIAS CELULARES EM 3D; INVADOPODIA DEGRADACAO MEDIADA; PROTEASES INVADOPODIAL; MICROAMBIENTE TUMORAL

9703/13381US=65 / Biol/Mol
Ragno P, Blasi F. uPAR and proteases in mobilization of hematopoietic stem cells. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 433-50. ISBN 978-0-387-69056-8.

UPAR; PROTEASES; CELULAS ESTAMINAIS HEMATOPOIETICAS

9704/13381US=65 / Biol/Mol
Degryse B. The urokinase receptor and integrins constitute a cell migration signalosome. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 451-74. ISBN 978-0-387-69056-8.

RECEPTOR DE UROCINASE; INTEGRINAS; MIGRACAO CELULAR

9705/13381US=65 / Biol/Mol
Zamai M, Malengo G, Caiolfa VR. Measuring uPAR dynamics in live cells. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 475-93. ISBN 978-0-387-69056-8.

UPAR; MEDICAO DINAMICA; CELULAS VIVAS; RECEPTORES DE ATIVADOR DE PLASMINOGENIO TIPO UROQUINASE

9706/13381US=65 / Biol/Mol
Kopitz C, Krüger A. Janus-Faced effects of Broad-Spectrum and specific MMP inhibition on metastasis. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 495-517. ISBN 978-0-387-69056-8.

JANUS-FACED; INIBICAO MMP ESPECIFICA; METASTASE; METASTASE MURINO; INIBICAO DE METALOPROTEINASES

9707/13381US=65 / Biol/Mol
Cox JH, Overall CM. Cytokine substrates: MMP regulation of inflammatory signaling molecules. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 519-39. ISBN 978-0-387-69056-8.

SUBSTRATOS DE CITOCINAS; MMP; REGULACAO DE MOLECULAS; SINALIZACAO INFLAMATORIAS; INFLAMACAO; QUIMIOCINAS

9708/13381US=65 / Biol/Mol
Lynch CC, Matrisian LM. Matrix metalloproteinases as key regulators of tumor-bone interraction. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 541-66. ISBN 978-0-387-69056-8.

METALOPROTEINASES; REGULADORES TUMOR OSSEO

9709/13381US=65 / Biol/Mol
Christensen IJ, Pappot H, Hoyer-Hansen G. The plasminogen activation system as a source of prognostic markers in cancer. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 569-86. ISBN 978-0-387-69056-8.

SISTEMA DE ATIVACAO DO PLASMINOGENIO; MARCADORES; PROGNOSTICO NO CANCER; UPA; UPAR; PAI-1; CANCER DE MAMA; CANCER COLORRETAL; CANCER DE PULMAO; CANCER GINECOLOGICO; CANCER DE PROSTATA

9710/13381US=65 / Biol/Mol
Lah TT, Obermajer N, Alonso MBD, Kos J. Cysteine cathepsins and cystatins as cancer biomarkers. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 587-625. ISBN 978-0-387-69056-8.

CATEPSINAS; CISTEINA; CISTATINAS; BIOMARCADORES DE CANCER; PEPTIDASES; PESQUISA CLINICA; CARCINOMA DE MAMA; CARCINOMA DE PROSTATA; CARCINOMA DO COLO DO UTERO; CARCINOMA DE OVARIO; CARCINOMA DE PULMAO; CARCINOMA DE COLON; CARCINOMA DE CABECA E PESCOCO; CARCINOMA DA BEXIGA; CARCINOMA DE PANCREAS; CANCER DE FIGADO; CARCINOMA HEPATOCELULAR; MELANOMA; MENINGIOMA; GLIOMA

9711/13381US=65 / Biol/Mol
Pennington CJ, Pilgrim S, Span PN, Sweep FC, Edwards DR. Novel degradome markers in breast cancer. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 627-43. ISBN 978-0-387-69056-8.

CANCER DE MAMA; MARCADORES DEGRADOME; ASSINATURAS DE EXPRESSAO; PERFIL DE EXPRESSAO DEGRADOME; METALOPROTEINASE POTENCIAL; MARCADORES INIBIDORES

9712/13381US=65 / Biol/Mol
Iljin K, Kilpinen S, Ivaska J, Kallioniemi O. Meta-analysis of gene expression microarray data: degradome genes in healthy and cancer tissues. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 645-61. ISBN 978-0-387-69056-8.

CANCER; GENES DEGRADOME; META-ANALISE DE DADOS; EXPRESSAO GENICA DE MICROARRAY

9713/13381US=65 / Biol/Mol
Laxton R, Ye S. Degradome gene polymorphisms. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 663-77. ISBN 978-0-387-69056-8.

GENE DEGRADOME; POLIMORFISMOS; MMP1; MMP2; MMP3; MMP9; MMP12

9714/13381US=65 / Biol/Mol
Frederiksen C, Lomholt AF, Nielsen HJ, Brünner N. TIMP-1 as a prognostic marker in colorectal cancer. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 679-96. ISBN 978-0-387-69056-8.

CANCER COLORRETAL; MARCADOR DE PROGNOSTICO; TIMP-1

9715/13381US=65 / Biol/Mol
Jacobsen B, Kjaergaard M, Gardsvoll H, Ploug M. Structure and inhibition of the urokinase-type plasminogen activator receptor. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 699-719. ISBN 978-0-387-69056-8.

ATIVADOR DO PLASMINOGENIO TIPO UROQUINASE; UPAR; ANTICORPOS MONOCLONAIS; ANTAGONISTAS PEPTIDICOS

9716/13381US=65 / Biol/Mol
Stoppelli MP, Andersen LM, Votta G, Andreasen PA. Engineered antagonists of uPA and PAI-1. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 721-58. ISBN 978-0-387-69056-8.

UPA; PAI-1; ATIVACAO DO PLASMINOGENIO; DISSEMINACAO DO CANCER; PROPRIEDADES BIOQUIMICAS; ADESAO CELULAR; MIGRACAO CELULAR; INVASAO CELULAR; PROLIFERACAO CELULAR; SOBREVIVENCIA; APOPTOSE; ATIVIDADE ENZIMATICA

9717/13381US=65 / Biol/Mol
Fingleton B. MMP inhibitor clinical trials-the past, present, and future. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 759-85. ISBN 978-0-387-69056-8.

INIBIDOR DE MMPS; ENSAIOS CLINICOS

9718/13381US=65 / Biol/Mol
Nagase H, Murphy G. Tailoring TIMPs for selective metalloproteinase inhibition. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 787-810. ISBN 978-0-387-69056-8.

TIMPS; INIBICAO SELETIVA DE METALOPROTEINASE; PROPRIEDADES BIOQUIMICAS

9719/13381US=65 / Biol/Mol
Yiotakis A, Dive V. Third-Generation MMP inhibitors: recent advances in the development of highly selective inhibitors. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 811-25. ISBN 978-0-387-69056-8.

INIBIDORES DE MMP; GRUPOS DE LIGACAO DE ZINCO; FOSFINICOS; TRANSICAO ANALOGOS

9720/13381US=65 / Biol/Mol
Fields GB. Protease-activated delivery and imaging systems. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 827-51. ISBN 978-0-387-69056-8.

PROTEASE; SISTEMAS DE IMAGEM; PRO-DROGAS; SISTEMA DE ENTREGA

Primeira | Anterior | Próxima | Última